Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
Submitted by
admin
on April 30, 2013 - 8:15am
Source:
Forbes
News Tags:
Pfizer
Merck
diabetes
ertugliflozin
R&D
Headline:
What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D
Do Not Allow Advertisers to Use My Personal information
